• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加蓬感染恶性疟原虫疟疾儿童使用50毫克青蒿琥酯栓剂后血浆中青蒿琥酯和双氢青蒿素的水平。

Plasma levels of artesunate and dihydroartemisinin in children with Plasmodium falciparum malaria in Gabon after administration of 50-milligram artesunate suppositories.

作者信息

Halpaap B, Ndjave M, Paris M, Benakis A, Kremsner P G

机构信息

Department of Pharmacology, University Medical Centre, Geneva, Switzerland.

出版信息

Am J Trop Med Hyg. 1998 Mar;58(3):365-8. doi: 10.4269/ajtmh.1998.58.365.

DOI:10.4269/ajtmh.1998.58.365
PMID:9546420
Abstract

A thermostable suppository of artesunate (artesunic acid) has been developed. In Gabon, 12 children with Plasmodium falciparum malaria received two administrations of this suppository in a 4-hr interval. Parasitemia and fever were then measured and the plasma levels of artesunate and its active metabolite, dihydroartemisinin, were determined by means of a reversed phase high-pressure liquid chromatography method using reductive electrochemical detection. Substantial parasite clearance (97-100%) was noted 24 hr after the beginning of the treatment and body temperature had returned to normal. Absorption, metabolism, and elimination of artesunate were rapid. Mean values of maximum plasma levels (Cmax) and maximum concentration peak times (tmax) were evaluated. The Cmax of dihydroartemisinin (0.18 +/- 0.10 microg/ml [mean +/- SE]) was higher than the Cmax of artesunate (0.09 +/- 0.04 microg/ml) and the tmax of dihydroartemisinin (1.13 +/- 0.58 hr) was higher than the tmax of artesunate (0.58 +/- 0.19 hr). Plasma levels 30 min after the second suppository administration were not consistently higher than those found 30 min after the first administration.

摘要

已研制出一种青蒿琥酯(青蒿素酸)的热稳定栓剂。在加蓬,12名患恶性疟原虫疟疾的儿童在4小时间隔内接受了两次这种栓剂给药。随后测量了疟原虫血症和发热情况,并采用还原电化学检测的反相高压液相色谱法测定了青蒿琥酯及其活性代谢物双氢青蒿素的血浆水平。治疗开始24小时后观察到疟原虫大量清除(97 - 100%),体温恢复正常。青蒿琥酯的吸收、代谢和消除迅速。评估了最大血浆水平(Cmax)和最大浓度峰值时间(tmax)的平均值。双氢青蒿素的Cmax(0.18±0.10微克/毫升[平均值±标准误])高于青蒿琥酯的Cmax(0.09±0.04微克/毫升),双氢青蒿素的tmax(1.13±0.58小时)高于青蒿琥酯的tmax(0.58±0.19小时)。第二次栓剂给药后30分钟的血浆水平并不始终高于第一次给药后30分钟的水平。

相似文献

1
Plasma levels of artesunate and dihydroartemisinin in children with Plasmodium falciparum malaria in Gabon after administration of 50-milligram artesunate suppositories.加蓬感染恶性疟原虫疟疾儿童使用50毫克青蒿琥酯栓剂后血浆中青蒿琥酯和双氢青蒿素的水平。
Am J Trop Med Hyg. 1998 Mar;58(3):365-8. doi: 10.4269/ajtmh.1998.58.365.
2
Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.青蒿琥酯栓剂与肌肉注射蒿甲醚治疗巴布亚新几内亚儿童重症疟疾的比较。
Antimicrob Agents Chemother. 2006 Mar;50(3):968-74. doi: 10.1128/AAC.50.3.968-974.2006.
3
Pharmacokinetics/Pharmacodynamics findings after repeated administration of ARTESUNATE thermostable suppositories (RECTOCAPS) in Vietnamese patients with uncomplicated malaria.青蒿琥酯热稳定栓剂(RECTOCAPS)在越南非复杂性疟疾患者中重复给药后的药代动力学/药效学研究结果
Eur J Drug Metab Pharmacokinet. 2006 Jan-Mar;31(1):41-5. doi: 10.1007/BF03190641.
4
Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.疟疾患者直肠给予青蒿琥酯后青蒿琥酯和双氢青蒿素的群体药代动力学
PLoS Med. 2006 Nov;3(11):e444. doi: 10.1371/journal.pmed.0030444.
5
Pharmacokinetics of oral artesunate in children with moderately severe Plasmodium falciparum malaria.口服青蒿琥酯在中度严重恶性疟原虫疟疾患儿中的药代动力学
Trans R Soc Trop Med Hyg. 1997 Mar-Apr;91(2):195-8. doi: 10.1016/s0035-9203(97)90222-4.
6
Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria.口服青蒿琥酯在健康志愿者和非复杂性恶性疟患者中的比较药代动力学和效应动力学
Am J Trop Med Hyg. 2001 Dec;65(6):717-21. doi: 10.4269/ajtmh.2001.65.717.
7
Declining concentrations of dihydroartemisinin in plasma during 5-day oral treatment with artesunate for Falciparum malaria.用青蒿琥酯口服治疗恶性疟5天期间,血浆中双氢青蒿素浓度下降。
Antimicrob Agents Chemother. 1999 Mar;43(3):690-2. doi: 10.1128/AAC.43.3.690.
8
A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria.青蒿琥酯治疗间日疟的药代动力学和药效学研究。
Am J Trop Med Hyg. 1998 Nov;59(5):823-7. doi: 10.4269/ajtmh.1998.59.823.
9
Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria.青蒿琥酯栓与口服青蒿琥酯联合甲氟喹治疗儿童急性恶性疟的对比临床试验。
Am J Trop Med Hyg. 1998 Jan;58(1):11-6. doi: 10.4269/ajtmh.1998.58.11.
10
Comparison of oral artesunate and dihydroartemisinin antimalarial bioavailabilities in acute falciparum malaria.急性恶性疟中口服青蒿琥酯与双氢青蒿素抗疟生物利用度的比较。
Antimicrob Agents Chemother. 2002 Apr;46(4):1125-7. doi: 10.1128/AAC.46.4.1125-1127.2002.

引用本文的文献

1
Phase I study on the pharmacokinetics of intravaginal, self-administered artesunate vaginal pessaries among women in Kenya.肯尼亚女性阴道内自行给药青蒿琥酯阴道栓的药代动力学I期研究。
PLoS One. 2025 Apr 9;20(4):e0316334. doi: 10.1371/journal.pone.0316334. eCollection 2025.
2
Phase I study on the pharmacokinetics of intravaginal, self-administered artesunate vaginal pessaries among women in Kenya.肯尼亚女性使用自行给药的青蒿琥酯阴道栓的药代动力学I期研究。
medRxiv. 2025 Feb 19:2024.07.08.24309596. doi: 10.1101/2024.07.08.24309596.
3
Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models.
二氢青蒿素局部给药治疗临床前小鼠模型中人乳头瘤病毒诱导的肛门生殖器发育不良的疗效。
Viruses. 2022 Jul 26;14(8):1632. doi: 10.3390/v14081632.
4
Endoperoxide Drug Cross-Resistance Patterns for Plasmodium falciparum Exhibiting an Artemisinin Delayed-Clearance Phenotype.表现出青蒿素清除延迟表型的恶性疟原虫的内过氧化物药物交叉耐药模式
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6952-6956. doi: 10.1128/AAC.00857-16. Print 2016 Nov.
5
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration.综述了静脉、肌肉、口服和直肠给药后青蒿琥酯及其活性代谢物双氢青蒿素的临床药代动力学。
Malar J. 2011 Sep 13;10:263. doi: 10.1186/1475-2875-10-263.
6
Pharmacokinetics and pharmacodynamics of a new ACT formulation: Artesunate/Amodiaquine (TRIMALACT) following oral administration in African malaria patients.一种新型青蒿琥酯联合阿莫地喹复方疗法(TRIMALACT)在非洲疟疾患者口服给药后的药代动力学和药效学
Eur J Drug Metab Pharmacokinet. 2009 Jul-Sep;34(3-4):133-42. doi: 10.1007/BF03191163.
7
Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.药物基因组学在疟疾治疗中的应用:成功化疗的整体方法。
Pharmacogenomics. 2009 Mar;10(3):435-49. doi: 10.2217/14622416.10.3.435.
8
Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies.用于疟疾治疗的直肠用青蒿素:基于临床研究中个体患者数据的疗效与安全性综述
BMC Infect Dis. 2008 Mar 28;8:39. doi: 10.1186/1471-2334-8-39.
9
Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.疟疾患者直肠给予青蒿琥酯后青蒿琥酯和双氢青蒿素的群体药代动力学
PLoS Med. 2006 Nov;3(11):e444. doi: 10.1371/journal.pmed.0030444.
10
Pharmacokinetics/Pharmacodynamics findings after repeated administration of ARTESUNATE thermostable suppositories (RECTOCAPS) in Vietnamese patients with uncomplicated malaria.青蒿琥酯热稳定栓剂(RECTOCAPS)在越南非复杂性疟疾患者中重复给药后的药代动力学/药效学研究结果
Eur J Drug Metab Pharmacokinet. 2006 Jan-Mar;31(1):41-5. doi: 10.1007/BF03190641.